Background Coronavirus disease 2019 (COVID-19) is a rapidly spreading global pandemic. The clinical characteristics of COVID-19 have been reported; however, there is limited research investigating the clinical characteristics of COVID-19 in the Middle East. This study aims to investigate the clinical, radiological and therapeutic characteristics of patients diagnosed with COVID19 in Saudi Arabia. Methods This study is a retrospective single-centre case series study. We extracted data for patients who were admitted to the Al-Noor Specialist Hospital with a PCR confirming SARS-COV-2 between 12th and 31st of March 2020. Descriptive statistics were used to describe patients’ characteristics. Continuous data were reported as mean ± SD. Chi-squared test/Fisher test were used as appropriate to compare proportions for categorical variables. Results A total of 150 patients were hospitalised for COVID-19 during the study period. The mean age was 46.1 years (SD: 15.3 years). The most common comorbidities were hypertension (28.8%, n = 42) and diabetes mellitus (26.0%, n = 38). Regarding the severity of the hospitalised patients, 105 patients (70.0%) were mild, 29 (19.3%) were moderate, and 16 patients (10.7%) were severe or required ICU care. Conclusion This case series provides clinical, radiological and therapeutic characteristics of hospitalised patients with confirmed COVID-19 in Saudi Arabia.
【초록키워드】 COVID-19, Coronavirus disease 2019, COVID19, Clinical characteristics, severity, Diabetes Mellitus, Comorbidity, hypertension, Saudi Arabia, global pandemic, PCR, Characteristics, therapeutic, Research, Patient, Mild, age, Hospitalised patients, moderate, retrospective, Middle East, ICU care, study period, Descriptive statistics, specialist, hospitalised, radiological, Result, proportion, reported, diagnosed, required, case sery, provide, were used, hospitalised patient, 105 patient, characteristics of patient, Continuous, variables, 【제목키워드】 Saudi Arabia, clinical, therapeutic, radiological, characteristics of patient, with COVID-19,